Kingsview Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Kingsview Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$487K	Buy	925 +10	+1%	+$5.61K	0.01%	990
2026 Q1	$514K	Sell	915 -45	-5%	-$28.9K	0.01%	894
2025 Q4	$649K	Sell	960 -20	-2%	-$13.6K	0.01%	764
2025 Q3	$626K	Sell	980 -16	-2%	-$9.71K	0.01%	735
2025 Q2	$534K	Hold	996	–	–	0.01%	746
2025 Q1	$418K	Sell	996 -10	-1%	-$4.34K	0.01%	781
2024 Q4	$416K	Buy	1,006 +3	+0.3%	+$1.32K	0.01%	802
2024 Q3	$507K	Buy	+1,003	New	+$487K	0.01%	718
2022 Q2	–	Sell	-368	Closed	-$201K	–	858
2022 Q1	$201K	Sell	368 -450	-55%	-$237K	0.01%	818
2021 Q4	$539K	Sell	818 -933	-53%	-$586K	0.02%	553
2021 Q3	$1.09M	Sell	1,751 -25	-1%	-$16.8K	0.05%	346
2021 Q2	$1.14M	Buy	1,776 +187	+12%	+$103K	0.06%	344
2021 Q1	$773K	Buy	+1,589	New	+$796K	0.04%	408

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Kingsview Wealth Management's IDXX Position: Q2 2026 in Review

Kingsview Wealth Management increased its Idexx Laboratories (IDXX) stake by 1.1% in Q2 2026, buying an estimated $5.61K and bringing the position to 925 shares worth $487K. The position accounts for 0.01% of the portfolio, ranked #990.

Kingsview Wealth Management first reported a position in IDXX in Q1 2021 and has held it in 13 quarters since. The position peaked at $1.14M in Q2 2021. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Kingsview Wealth Management held 925 shares of Idexx Laboratories worth $487K as of Q2 2026.
Kingsview Wealth Management bought 10 Idexx Laboratories shares in Q2 2026, an estimated $5.61K.
Idexx Laboratories made up 0.01% of Kingsview Wealth Management's portfolio in Q2 2026, its #990 holding.
Kingsview Wealth Management first reported a position in Idexx Laboratories in Q1 2021 and has held it in 13 quarters since.
Kingsview Wealth Management's Idexx Laboratories position peaked at $1.14M in Q2 2021.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Kingsview Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.